HER2-amplification was most often present in biopsies of oesophagus and gastric cardia adenocarcinomas (27% and 18%, respectively); amplification was less frequent in adenocarcinomas of the body and antral region (7%). The gene discussed is ERBB2; the disease is adenocarcinoma.